Explore
Trendline
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Read More
Trendline
Bruker Corporation Reports Q1 2026 Financial Results with Revenue Growth
Bruker Corporation Reports Q1 2026 Financial Results with Revenue Growth
Read More
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with Revenue Growth
Read More
Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Read More
Trendline
Veracyte Reports Strong Revenue Growth in First Quarter 2026
Veracyte Reports Strong Revenue Growth in First Quarter 2026
Read More
Trendline
IonQ Reports Record Q1 2026 Revenue, Raises Full-Year Guidance
IonQ Reports Record Q1 2026 Revenue, Raises Full-Year Guidance
Read More
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth
Read More
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
Read More
Trendline
GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook
GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook
Read More
Trendline
GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook
GeneDx Reports Strong Q1 2026 Financial Results and Updates Outlook
Read More
Trendline
GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook
GeneDx Reports Strong Q1 2026 Financial Results, Updates Yearly Outlook
Read More
Trendline
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
Read More
